Yeonhee Park

Dr. Yeonhee Park

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 February 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YPYeonhee Park
Yeonhee Park
The Mann-Whitney-Wilcoxon test, often referred to as the Mann-Whitney U test or Wilcoxon rank-sum test, is a non-parametric statistical test used to compare two independent groups when the dependent variable is ordinal or continuous but not normally distributed. It’s particularly useful for small sample sizes or when the assumptions of parametric tests, such as the t-test, are violated, including cases where the data is skewed. This study focuses on the Mann-Whitney-Wilcoxon test for ordinal data, which frequently arises in biomedical research when the proportional odds assumption does not hold. Currently, there are no optimal two-stage randomized clinical trial designs utilizing the Mann-Whitney-Wilcoxon test. To address this research gap, our study proposes optimal two-stage designs based on the Mann-Whitney-Wilcoxon test. We demonstrate the application of these designs through illustrative examples and evaluate their operating characteristics.

Verified
Journal Article
Open access
PDF file
THTaylor S Hulahan
Taylor S Hulahan
LSLaura Simmons Spruill
Laura Simmons Spruill
EWElizabeth N. Wallace
Elizabeth N. Wallace
YPYeonhee Park
Yeonhee Park
RWRobert B. West
Robert B. West
PAPeggi Angel
Peggi Angel
Ductal carcinoma in situ (DCIS) is a heterogeneous breast disease that remains challenging to treat due to its unpredictable progression to invasive breast cancer (IBC). Contemporary literature has become increasingly focused on extracellular matrix (ECM) alterations with breast cancer progression. However, the spatial regulation of the ECM proteome in DCIS has yet to be investigated in relation to IBC. We hypothesized that DCIS and IBC present distinct ECM proteomes that could discriminate between these pathologies. Tissue sections of pure DCIS, mixed DCIS-IBC, or pure IBC (n = 22) with detailed pathological annotations were investigated by multiplexed spatial proteomics. Across tissues, 1,005 ECM peptides were detected in pathologically annotated regions and their surrounding extracellular microenvironments. A comparison of DCIS to IBC pathologies demonstrated 43 significantly altered ECM peptides. Notably, eight fibrillar collagen peptides could distinguish with high specificity and sensitivity between DCIS and IBC. Lesion-targeted proteomic imaging revealed heterogeneity of the ECM proteome surrounding individual DCIS lesions. Multiplexed spatial proteomics reported an invasive cancer field effect, in which DCIS lesions in closer proximity to IBC shared a more similar ECM profile to IBC than distal counterparts. Defining the ECM proteomic microenvironment provides novel molecular insights relating to DCIS and IBC.

1 September 2022 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
YPYeonhee Park
Yeonhee Park
Challenges and opportunities in biomarker-driven trials: adaptive randomization Yeonhee Park

Verified
Journal Article
Open access
PDF file
YPYeonhee Park
Yeonhee Park
Personalized medicine has been emerging to take into account individual variability in genes and environment. In the era of personalized medicine, it is critical to incorporate the patients’ characteristics and improve the clinical benefit for patients. The patients’ characteristics are incorporated in adaptive randomization to identify patients who are expected to get more benefit from the treatment and optimize the treatment allocation. However, it is challenging to control potential selection bias from using observed efficacy data and the effect of prognostic covariates in adaptive randomization. This paper proposes a personalized risk-based screening design using Bayesian covariate-adjusted response-adaptive randomization that compares the experimental screening method to a standard screening method based on indicators of having a disease. Personalized risk-based allocation probability is built for adaptive randomization, and Bayesian adaptive decision rules are calibrated to preserve error rates. A simulation study shows that the proposed design controls error rates and yields a much smaller number of failures and a larger number of patients allocated to a better intervention compared to existing randomized controlled trial designs. Therefore, the proposed design performs well for randomized controlled clinical trials under personalized medicine.

13 June 2024 in Glycobiology
Verified
Journal Article
Closed access
PDF file
DRDenys Rujchanarong
Denys Rujchanarong
LSLaura Simmons Spruill
Laura Simmons Spruill
GSGEORGE SANDUSKY
GEORGE SANDUSKY
YPYeonhee Park
Yeonhee Park
AMAnand Mehta
Anand Mehta
PAPeggi Angel
Peggi Angel
Higher breast cancer mortality rates continue to disproportionally affect black women (BW) compared to white women (WW). This disparity is largely due to differences in tumor aggressiveness that can be related to distinct ancestry-associated breast tumor microenvironments (TMEs). Yet, characterization of the normal microenvironment (NME) in breast tissue and how they associate with breast cancer risk factors remains unknown. N-glycans, a glucose metabolism-linked post-translational modification, has not been characterized in normal breast tissue. We hypothesized that normal female breast tissue with distinct Breast Imaging and Reporting Data Systems (BI-RADS) categories have unique microenvironments based on N-glycan signatures that varies with genetic ancestries. Profiles of N-glycans were characterized in normal breast tissue from BW (n = 20) and WW (n = 20) at risk for breast cancer using matrix assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI). A total of 176 N-glycans (32 core-fucosylated and 144 noncore-fucosylated) were identified in the NME. We found that certain core-fucosylated, outer-arm fucosylated and high-mannose N-glycan structures had specific intensity patterns and histological distributions in the breast NME dependent on BI-RADS densities and ancestry. Normal breast tissue from BW, and not WW, with heterogeneously dense breast densities followed high-mannose patterns as seen in invasive ductal and lobular carcinomas. Lastly, lifestyles factors (e.g. age, menopausal status, Gail score, BMI, BI-RADS) differentially associated with fucosylated and high-mannose N-glycans based on ancestry. This study aims to decipher the molecular signatures in the breast NME from distinct ancestries towards improving the overall disparities in breast cancer burden.